Can Fenbendazole For Humans Treat Stage 4 Cancer?

Fenbendazole is a drug used to treat parasitic worm infections in animals (common brand names include Pancur and Safe-Guard). However, it’s currently being touted as a cancer treatment, particularly for patients with Stage 4 cancer. This claim is based on anecdotal reports from people who have claimed that fenbendazole helped them go into remission.

These claims are false and have not been proven by medical professionals. While some studies using cancer cells in petri dishes and mice show that fenbendazole can slow down the growth of certain types of cancers, there is no evidence that it has any effect on people who have already been diagnosed with and are receiving conventional cancer treatments.

What is known about fenbendazole for humans is that it works by interfering with the formation of microtubules. Cells establish their shape and structure through a protein scaffolding system called the cytoskeleton, which is composed of microtubules. Fenbendazole interferes with this process by preventing the formation of new microtubules and blocking existing ones from binding to other molecules. This inhibits the movement of GLUT transporters, thereby restricting insulin-stimulated glucose uptake in cancer cells and starving them of energy.

In addition, fenbendazole can also disrupt the function of mitochondria. This is a big deal because mitochondria are the organelles that generate cellular energy. Without energy, cells cannot grow and repair themselves as they are supposed to do. Essentially, if the mitochondria cannot produce ATP, the cellular machinery can no longer function properly and the cancer cells are likely to die.

Moreover, fenbendazole for humans can be used in conjunction with other treatments to boost their effectiveness. According to a study published in Scientific Reports, the combination of fenbendazole and DCA (deoxycytidine-5′-deaza-2′-deoxycytidine) significantly reduces the number of tumors in mice. Furthermore, the authors found that fenbendazole alone reduced the number of lung metastases from melanoma, colorectal, and prostate cancers.

A specialist cancer information nurse at Cancer Research UK told Full Fact that there isn’t any evidence that fenbendazole can cure cancer in humans, despite some promising results in cell studies and animal models. She said that people who are claiming that fenbendazole cures their cancer are using this drug as an alternative to standard treatments, such as chemotherapy, which is known to be effective in many cases.

This is dangerous, as fenbendazole could potentially mask the effects of other treatments that are needed to keep a patient alive and well. Additionally, the anecdotal accounts of people who have reported being cured by fenbendazole aren’t reliable, since there are often other factors that could account for their remission. For example, Joe Tippens’ anecdotal story of going into remission after taking fenbendazole may be partly due to the conventional cancer treatments he received at the same time that he started taking the drug. If this is the case, it would be difficult to replicate his success with fenbendazole for cancer in other patients, as it’s not a valid treatment method and there are no randomized clinical trials showing that fenbendazole is an effective cancer treatment in people.